INN monograph
Erlotinib Hydrochloride
L01XE03 · POM
Verified · Updated 23 Jul 2026
Kenya market
Wholesale / list prices where loaded
Risk first
Contraindications
No structured CI text — verify product SmPC.
Point of care
Dosing
Adult
See SmPC / STG for indication-specific dose.
Paediatric
Weight-based — use paediatric formulary / SmPC.
Renal
Check SmPC; many renally cleared drugs need CrCl adjustment.
Hepatic
Check SmPC in significant liver disease.
Safety
Drug interactions
No structured interaction monograph text. Use the multi-drug checker and SmPC.
Safety
Adverse effects
ADR text pending — consult SmPC.
Use
Indications
PPB Registered Human Medicine.
Pharmacology
Mode of action
Mechanism not yet curated for this INN — confirm SmPC.
ADME
Pharmacokinetics & PD
| Route | Film-Coated Tablet |
|---|
Kenya
Brands & prices
| Brand | Company | Pack | KES |
|---|---|---|---|
| Erlocip 25 | — | H2021/CTD7414/14568 (36 months) | 451.00 |
| Erlocip 100 | globalra@cipla.com | H2021/CTD7413/14567 (36 months) | 379.00 |
| Erlocip 150 | — | H2021/CTD7405/14549 (36 months) | 205.00 |
Special populations
Pregnancy & lactation
Pregnancy
See SmPC / obstetric guidance.
Lactation
See SmPC / lactation reference.
Diet
Food & alcohol
- Alcohol (Beer, Wine, Spirits) Avoid or limit alcohol consumption while taking Erlotinib Hydrochloride. Alcohol may alter drug metabolism, enhance drowsiness, or exacerbate gastrointestinal irritation.
- Dietary Hydration & Meals Take Erlotinib Hydrochloride with a full glass of water. If gastrointestinal upset occurs, take with or after light meals.
Trust
Sources & disclaimer
Source: MyDrugIndex clinical corpus
Decision support only — not a substitute for clinical judgment, product SmPC, or Kenya STG/EML.